PRESS RELEASE published on 02/14/2023 at 13:44, 3 years 3 months ago Turkiye Garanti Bankasi A.S.: Coupon Rate of Subordinated Debt Securities to Qualified Investors
PRESS RELEASE published on 02/07/2023 at 12:57, 3 years 3 months ago Turkiye Garanti Bankasi A.S.: Debt Instrument Issuance CMB Application
PRESS RELEASE published on 02/01/2023 at 07:53, 3 years 3 months ago Turkiye Garanti Bankasi A.S.: Announcement regarding forward looking statements on the expectations for the year 2023
PRESS RELEASE published on 02/01/2023 at 07:49, 3 years 3 months ago Turkiye Garanti Bankasi A.S.: BRSA Consolidated Earnings Presentation dated 31 December 2022
PRESS RELEASE published on 01/30/2023 at 13:06, 3 years 3 months ago Turkiye Garanti Bankasi A.S.: Issuance of debt instrument abroad under the Bank's Medium Term Note program
PRESS RELEASE published on 01/21/2023 at 12:35, 3 years 4 months ago Turkiye Garanti Bankasi A.S.: Board of Directors resolution regarding the foreign debt instrument issue limit
PRESS RELEASE published on 01/10/2023 at 15:38, 3 years 4 months ago Turkiye Garanti Bankasi A.S.: Coupon payment of Subordinated Debt Securities to Qualified Investors
PRESS RELEASE published on 01/07/2023 at 08:32, 3 years 4 months ago Turkiye Garanti Bankasi A.S.: Coupon Rate of Subordinated Debt Securities to Qualified Investors
Published on 05/22/2026 at 14:04, 8 hours 48 minutes ago Wi2Wi Corporation Announces First Quarter 2026 Financial Results (Unaudited)
Published on 05/22/2026 at 14:00, 8 hours 52 minutes ago Imagine Health Achieves Teaching Facility Status Through University of Calgary Faculty Partnership
Published on 05/22/2026 at 14:00, 8 hours 52 minutes ago CCL Industries Inc. Announces Renewal of Normal Course Issuer Bid and Approval of Automatic Securities Purchase Plan
Published on 05/22/2026 at 14:00, 8 hours 52 minutes ago Dateline Appoints Alvarez & Marsal to Manage Colosseum Development
Published on 05/22/2026 at 22:05, 47 minutes ago Abivax présente ses résultats financiers du T1 2026 et les données à trois ans de l’étude 108, un essai d’extension ouvert de phase 2a/2b évaluant l’obéfazimod après réduction de dose dans la RCH
Published on 05/22/2026 at 22:05, 47 minutes ago Abivax Presents Q1 2026 Financial Results and Reports Three-Year Interim Data from Study 108, a Phase 2a/2b Open-Label Extension Trial of Obefazimod Following Dose De-Escalation in Patients with UC
Published on 05/22/2026 at 19:51, 3 hours 1 minute ago Turkiye Garanti Bankasi A.S.: Brokerage Houses Warrants Redemption Prices
Published on 05/22/2026 at 18:33, 4 hours 19 minutes ago Update on Coupon payment due on 23 May 2026 and Preparation of the Green Bond Restructuring
Published on 05/22/2026 at 18:30, 4 hours 22 minutes ago Annual General Meeting of Curatis Holding AG approved all proposals of the Board of Directors
Published on 05/22/2026 at 19:35, 3 hours 17 minutes ago PROJET D'EVOLUTION DE SA GOUVERNANCE ET LA NOMINATION D'UN PRESIDENT DU DIRECTOIRE PAR INTERIM
Published on 05/22/2026 at 18:05, 4 hours 46 minutes ago Déclaration hebdomadaire d'opérations effectuées du 18 au 22 mai 2026
Published on 05/22/2026 at 18:05, 4 hours 46 minutes ago Disclosure of transactions in own shares from May 18 to May 22, 2026
Published on 05/22/2026 at 12:52, 9 hours 59 minutes ago Communiqué du Conseil d’administration – Assemblée Générale du 22 mai 2026
Published on 05/22/2026 at 12:52, 9 hours 59 minutes ago Release from the Board of Directors - Shareholders’ Meeting of May 22, 2026
